I recently sat down with Jason Barkeloo, Founder and Chair of Open Therapeutics, at one of my favorite meeting spots, YSB. Barkeloo’s vision has resulted in an open collaboration company. They bring scientists together to share data and focus on developing technologies that will address global health issues. Specializing in synthetic biology, the company believes in “eliminating research silos, encouraging scientific peer-to-peer communication and stimulating collaboration in scientific research.”
Barkeloo wants to partner with SOCHE to aggressively bring student researchers into the mix. Not only will students gain access to advanced biomedical research, the goal of their involvement is multi-fold: 1) increase student research contributions to the open source network; 2) create global connections between new and seasoned scientists; 3) advance the mindset and culture of collaboration among the scientific community and its next generation leadership; 4) perpetuate research done for the global good and solving world health issues; and 5) the list holds the potential to go on and on.
Bravo, Jason and Open Therapeutics!